• NEBANNER

Shanghai waxay bilawday dawooyinka patent-ka ee Shiinaha iyo diyaarinta fudud iyo daawaynta aan dawooyinka ahayn si dadka looga caawiyo la dagaalanka ifilada guga

 

1.Shanghai waxa ay bilawday dawooyinka patent dhaqameed ee Shiinaha iyo diyaargarow fudud iyo daawaynta aan dawooyinka ahayn si ay dadka uga caawiyaan la dagaalanka ifilada guga.

Maamulka Dawladda Hoose ee Shanghai ee Daawada-dhaqameed ee Shiinaha ayaa shaaca ka qaaday 5-tii in Saldhigga Qaranka ee Ka-hortagga iyo Xakamaynta Cudurrada Faafa ee Daawada Shiinaha (Shanghai) uu hoggaanka u qabtay samaynta Qorshaha Ka-hortagga iyo Xakamaynta Daawada Shiinaha ee 2023 Hargabka Guga ee Shanghai (Trial) (Hadda ka dib loo tixraaco qorshaha), waxay soo jeedisay fahamka dawada Shiinaha ee hargabka, oo la sameeyay dawooyinka Shiinaha ee loogu talagalay dadka waaweyn iyo carruurta oo ku saleysan kala duwanaanta cilladda, waxayna bilaabeen dhowr daawooyin dhaqameed oo Shiineys ah oo patent ah iyo diyaargarow fudud iyo daaweyn aan daroogo ahayn oo loogu talagalay ka hortagga iyo xakameynta hargabka. .

Jiilaalka iyo gu'ga, cimiladu waa diirimaad iyo qabow, kala duwanaanshaha heerkulka u dhexeeya habeen iyo maalin waa isbedbedelaya, cudurrada faafa ee xilliyada waxay galeen cudurro iyo cudurro aad u sarreeya.Dhawaan, tirada bukaannada qaba hargabka A iyo cudurrada kale ee ay heleen isbitaallada waaweyn ee Shanghai ayaa kordhay.Qorshuhu wuxuu ujeedkiisu yahay in la siiyo ciyaar buuxda sifaadka iyo faa'iidooyinka daawada dhaqameed ee Shiinaha ee ka hortagga iyo daaweynta hargabka.

Mr. xaddidaya.Qaar ka mid ah carruurta daciifka ah iyo dadka waayeelka ah ee qaba cudurrada hoose waxay keeni karaan dhibaatooyin kale sababtoo ah cudurrada dibadda, taas oo ah diiradda ka hortagga iyo daaweynta dawooyinka dhaqanka Shiinaha iyo daawada reer galbeedka.Waxa uu saxafiyiinta u sheegay in dawo dhaqameedka Shiinaha ay aaminsan yihiin in hargabku uu ka tirsan yahay qaybta qabowga hadda jirta.Marka loo eego fahamka dhaqameed, ogaanshaha iyo daawaynta waxay inta badan ku saleysan yihiin nidaamka kala duwanaanshaha cilladda iyo hababka daaweynta ee lixda meridians, kala soocidda cilladda ee Weiqi iyo Yingxue, iyo habka kala soocida cilladda iyo habka daaweynta ee saddexda jiao, iyo feejignaanta waxaa lagu bixiyaa codsiga isku-dhafka ah ee xoojinta iyo baabi'inta arrimaha cudurada faafa ee heerarka iyo heerarka.

"Hargabku inta badan waa is-xakameyn waxaana lagu daweyn karaa waqti gaaban ka dib daaweynta calaamadaha guud iyo faragelinta TCM."Zhang Wei waxa uu tilmaamay in, marka lagu daro dawooyinka patent-ka ee Chinese-ka ah iyo diyaarinta fudud ee lagu taliyey nidaamka, cusbitaalada waaweyn ee TCM ee Shanghai ayaa khibrad qani ah u leh ogaanshaha iyo daawaynta hargabka, iyo sidoo kale diyaarinta cusbitaalka iyo qoritaanka taxane ah.

Waxaa la sheegay in gudbinta dhawaantan ay u badan tahay H1N1.Marka loo barbar dhigo hargabka caadiga ah, aad buu u faafaa, qandho sare ayuu leeyahay oo wuu sii dheeraadaa, wuxuu leeyahay calaamado habaysan oo muuqda, wuxuuna leeyahay cudur dheer.

Xue Zheng, oo ah qoraaga barnaamijka carruurta iyo agaasimaha waaxda caafimaadka carruurta ee isbitaalka degmada Shanghai ee daawada dhaqameed ee Shiinaha, ayaa aaminsan in carruurta da'doodu ka yar tahay 5 sano ay u nugul yihiin hargabka.Carruurtu waxay u nugul yihiin hargabka waxayna leeyihiin calaamado aad u daran sababtoo ah sambabada jilicsan.Daawada dhaqameed ee Shiinaha ayaa door aad u wanaagsan ka ciyaarta ka hortagga iyo daaweynta hargabka carruurta, gaar ahaan daaweynta hargabka A, kaas oo xakameyn kara faafitaanka iyo qoto dheeraanta fayraska, si degdeg ah u wanaajiya calaamadaha, oo leh muuqaal ballaadhan.Dhakhaatiirta carruurta ee cisbitaalada waaweyn ee Shiinaha iyo Galbeedka ayaa sidoo kale leh diyaargarow cusbitaal oo qaan-gaar ah oo si weyn loogu isticmaalo bukaan-socodka.

Qorshuhu waxa uu dajiyay qoritaanka heshiiska dawooyinka dhaqameed ee Shiinaha iyo dawooyinka patent-ka ee Chinese-ka ah iyo diyaarinta fudud ee daaweynta hargabka carruurta, waxa kale oo uu soo jeediyay habab daaweyn dibadeed fudud oo jaban oo dawo dhaqameed ah.Waalidiintu waxay samayn karaan faragelinta daawaynta dhaqameed ee Shiinaha iyada oo loo marayo hababka daaweynta dibadda sida dietotherapy, duugista, dhibcaha dhegta, codsiga iyo daawaynta fooxa si ay uga caawiso carruurta inay si dhakhso ah u hagaajiyaan calaamadaha oo ay uga soo kabtaan caafimaadka sida ugu dhakhsaha badan.

 src=http___ss2.meipian.me_users_40331628_7415fc22e095485c9477de7f6f31242f.jpg_meipian-raw_bucket_ivwen_key_dXNlcnMvNDAzMzE2NDMjNjgWk1k ZTdmNmYzMTI0MmYuanBn_sign_14377f434be40c5bb73ac7c24c.webp

 

 

Cilmi-baarayaasha 2.Scientific waxay heleen taxane ah anti-hepatoma maaddooyinka firfircoon ee dhirta daawada Artemisia annua.

Machadka Kunming ee Botany, Akadeemiyada Sayniska Shiinaha, ayaa ku dhawaaqay 21-kii in kooxda cilmi-baarista Chen Jijun ay heleen taxane cusub oo sesquiterpene dimers ah oo leh firfircoonida kansarka beerka ee ka timaadda dhirta daawada Artemisia scoparia.Natiijooyinka cilmi-baarista ee laxidhiidha ayaa dhawaan lagu daabacay joornaalka caanka ah ee caalamiga ah ee gudbinta calaamadaha iyo daaweynta la beegsaday.

Kansarka beerka waa buro halis ah oo si ba'an u halis gelisa caafimaadka aadanaha.Sannad kasta, tirada kiisaska cusub ee kansarka beerka ee adduunka ayaa kor u dhaafa 840000, tirada dhimashada ee uu keeno kansarka beerka ayaa gaareysa 780000, halka qiyaastii 50% kiisaska cusub ay ka dhacaan Shiinaha.Waqtigan xaadirka ah, waxaa jira afar tyrosine kinase inhibitors, sorafenib, regafinil, lovatinib iyo cabotinib, hal vascular endothelial factor factor receptor 2 antagonist, ramolumab, iyo laba PD-1 inhibitors, navumab iyo pamuzumab, kuwaas oo loo isticmaalo daaweynta kiliinikada ee kansarka beerka. , laakiin nooca qaabdhismeedku waa mid fudud oo sahlan in la soo saaro caabbinta daroogada.

Sanadihii la soo dhaafay, kooxda cilmi-baarista Chen Jijun waxaa ka go'an in ay raadiyaan xeryahooda sunta rasaasta ka hortagga hepatoma iyo dawooyin hal abuur leh oo leh qaab-dhismeed gaar ah iyo habka cusub ee ficilka ee dhirta Artemisia, waxayna si guul leh u aasaaseen habka kala-soocidda oo isku daraya aqoonsiga jihada ee dimers sesquiterpene ee Artemisia. dhirta leh la socodka hawlaha anti-hepatoma.Daraasadani waxay ogaatay markii ugu horeysay in laga soosaaray Artemisia annua ay leedahay firfircooni xoog leh oo ka hortag ah oo ku saabsan saddex unug oo hepatoma ah, iyo markii ugu horeysay, 36 novel sesquiterpene dimers ee noocyada qaabdhismeedka 9 - Artemisia annua A1-A3, B1-B2, C1-C4 , D, E, F1-F15, G1-G8, H iyo anigu waxaan ka go'doonnay qaybta firfircoon ee Artemisia annua.

Daraasado dheeraad ah ayaa muujiyay in ka mid ah 36 novel sesquiterpene dimers, waxqabadka artemisinin G5 iyo G7 ayaa ahaa kan ugu fiican, taas oo u dhiganta kiliinikada koowaad ee daawada hepatoma sorafenib;Intaa waxaa dheer, artemisinin koonfurta G7 waxay muujisay xulashada iyo badbaadada ka wanaagsan sorafenib ee THLE-2 ee unugyada beerka caadiga ah;Isla mar ahaantaana, koonfurta artemisinin G7 waxay sidoo kale joojin kartaa faafinta unugyada HepG2 iyada oo la xakameynayo duullaanka iyo socdaalka unugyada hepatoma, taasoo keenta apoptosis iyo xannibista wareegga unugyada G2 / M.

Daraasadani waxay shaaca ka qaaday markii ugu horeysay taxane ah sesquiterpene dimers oo leh qalfoof cusub iyo qaab dhismeedka kala duwan ee Artemisia annua, waxay kobcisay noocyada qaab dhismeedka sesquiterpene dimers ee dhirta Artemisia, waxayna bixisay noocyo kala duwan oo molecules musharax ah iyo saldhig dawo oo muhiim u ah cilmi baarista cusub ee antibiyootiga. -daawoyinka hepatoma.

Ilaa hadda, kooxda cilmi-baarista Chen Jijun waxay go'doomiyeen oo ay aqoonsadeen 122 novel sesquiterpenoid dimers oo leh firfircoonida cagaarshowga ka hortagga Artemisia australis, Artemisia sinica, Artemisia medinalis, Artemisia cowtail iyo Artemisia mongolica, oo xisaabiya 52% tirada guud ee tirada 234 sequiterpeno Dhirta Artemisia ee adduunka.

u=1999229503,2857859641&fm=253&fmt=auto&app=138&f=JPEG.webp

 

JinDun Medicalwaxay leedahay iskaashi cilmi-baaris cilmiyeed oo muddo-dheer ah iyo ku-tallaalidda tignoolajiyada jaamacadaha Shiinaha.Iyada oo Jiangsu kheyraad caafimaad qani ah, waxay leedahay xiriir ganacsi oo muddo dheer India, Koonfur-bari Asia, South Korea, Japan iyo suuqyada kale.Waxa kale oo ay bixisaa adeegyada suuqa iyo iibka ee geeddi-socodka oo dhan laga bilaabo dhexe ilaa API alaabta dhammaatay.Ka faa'iidayso agabka la ururiyey ee Kiimikada Yangshi ee kimistariga fluorine si aad u bixiso adeegyo gaar ah oo kiimikaad ah oo loogu talagalay lammaanayaasha.Bixi habka hal-abuurka iyo adeegyada cilmi-baarista wasakhaysan si loo beegsado macaamiisha.

JinDun Medical wuxuu ku adkaysanayaa in la abuuro koox leh riyooyin, samaynta alaabooyin leh sharaf, taxadar leh, adag, oo dhan u baxa si ay u noqdaan lammaane la aamini karo iyo saaxiibka macaamiisha! xirfadlewax-soo-saarka dawooyinka la habeeyey(CMO) iyo R&D dawada la habeeyey iyo adeeg bixiyayaasha wax soo saarka (CDMO).


Waqtiga boostada: Mar-30-2023